5-amino-1mq subcutaneous injection | ≥99% Pure 5-amino-1mq subcutaneous injection dose Jantu

NAD+ BENEFITS Selective NNMT inhibition substrate-site targeting with minimal off-target activity in preclinical models NAD+ salvage modulation studied for increasing intracellular NAD+ and SAM availability Adipose metabolism investigated for suppression of adipocyte lipogenesis in 3T3-L1 models Small molecule distinct mechanism from peptide-based metabolic compounds (GLP-1 agonists, etc.) Defined pharmacology IC of 1.2 M confirmed in published enzymatic assays WHAT RESEARCHERS LOOK AT NNMT enzyme inhibition kinetics and SAM/1-MNA substrate balance NAD+ and SAM level changes in adipocyte and hepatocyte cell models Lipogenesis suppression in 3T3-L1 differentiated adipocyte assays Polyamine flux enzyme upregulation (ODC, SSAT) and histone methylation In vivo efficacy in diet-induced obesity (DIO) murine models

Analytical Verification (COA) Each batch of 5-Amino-1MQ supplied by Grail Formula undergoes independent third-party laboratory verification to confirm compound identity, assay content, purity and microbiological safety

Freeze-drying supports long-term storage stability and preserves compound integrity

Patients typically use it as part of a body-recomposition protocol alongside resistance training and nutrition

Every batch is tested through two independent third-party labs to evaluate four crucial characteristics for quality and safety